Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend

Global Summit

Session: Global Differences in Disease Management Guidelines (LARS Session)

PANEL Discussion

Friday, October 24, 2025
3:00 PM – 3:50 PM Central Time

    Virtual Panelist(s)

  • BH

    Bernhard Hellmich, MD

    Medius Kliniken
    Kirchheim unter Teck, Germany

    Disclosure(s): AbbVie/Abbott: Advisor or Review Panel Member (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); AstraZeneca: Advisor or Review Panel Member (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boehringer-Ingelheim: Advisor or Review Panel Member (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); CSL Vifor: Advisor or Review Panel Member (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); GlaxoSmithKlein(GSK): Advisor or Review Panel Member (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Merck/MSD: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Novartis: Advisor or Review Panel Member (Ongoing); Pfizer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Recordati: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

  • GF

    Gilda Ferreira, PhD

    Federal University of Minas Gerais
    Belo Horizonte, Minas Gerais, Brazil

    Disclosure(s): No financial relationships with ineligible companies to disclose

  • CM

    Chi Chiu Mok, MD,FRCP

    Tuen Mun Hospital
    Hong Kong, Hong Kong, China

    Disclosure(s): No financial relationships with ineligible companies to disclose